Effect of copper oxide wire particles dosage and feed supplement level on Haemonchus contortus infection in lambs.
The objective of the experiment was to determine the optimal dose of copper oxide wire particles (COWPs) to reduce infection of Haemonchus contortus in male lambs. Five to six-month-old hair breed lambs were housed on concrete and fed 450 (L; n = 25) or 675 g (H; n = 25) corn/soybean meal supplement and bermudagrass hay. In July, lambs were inoculated with 10,000 L(3) larvae (97% H. contortus; Day 0). Lambs were administered 0, 2, 4, or 6 g COWP on Day 28. Concentrations of copper in the liver were determined. There were no effects of supplement level on concentrations of copper in the liver and a linear relationship existed between COWP treatment and concentrations of copper in liver (P < 0.001). Least squares means of the 0, 2, 4, 6 g COWP treatments were 62.2, 135.7, 161.1, and 208.4 ppm (P < 0.001). Between Days 0 and 28, PCV declined and by Day 42, PCV of all COWP-treated lambs was markedly higher than control lambs and remained higher (COWP x day, P < 0.05). By Day 21, PCV was greater in the H compared with the L group of lambs (P < 0.001). Within 14 days of COWP treatment FEC declined from more than 8000 eggs/g (epg) to less than 250 epg in all COWP-treated lambs (COWP x day, P < 0.001). The numbers of H. contortus in the abomasum were greatly reduced in all COWP-treated groups of lambs and remaining nematodes were predominantly males. FEC were greater in L versus H supplemented lambs and values decreased to a greater extent in H lambs when treated with COWP (supplement x COWP; P < 0.02). The 2 g COWP was effective in alleviating H. contortus infection and reducing number of egg-laying nematodes in the abomasum with the lowest concentration of copper in the liver of the COWP treatment groups. PCV values were more favorable for lambs fed the higher level of supplement, especially when FEC were greater than 8000 epg.
Burke
J M
JM
Dale Bumpers Small Farms Research Center, USDA, ARS, Booneville, AR 72927, USA. jmburke@spa.ars.usda.gov
Miller
J E
JE
Olcott
D D
DD
Olcott
B M
BM
Terrill
T H
TH
D000018:Abomasum / Q000469:parasitology; D000821:Animal Feed; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003300:Copper / Q000008:administration & dosage* / Q000493:pharmacokinetics; D019587:Dietary Supplements; D005243:Feces / Q000469:parasitology; D005260:Female; D006188:Haemonchiasis / Q000188:drug therapy* / Q000378:metabolism / Q000469:parasitology / Q000662:veterinary*; D006189:Haemonchus / Q000254:growth & development* / Q000378:metabolism; D006400:Hematocrit / Q000662:veterinary; D008099:Liver / Q000378:metabolism / Q000469:parasitology; D008297:Male; D010270:Parasite Egg Count / Q000662:veterinary; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000469:parasitology*
D003300:Copper; C030973:cupric oxide